GSK has recently been ranked first in the Access to Medicine Index for the fifth consecutive time, taking a leadership position in research and development, pricing, manufacturing and distribution, and product donations.
The Index, which recognises GSK for its clear access to medicines strategy and company-wide ownership, is an independent measure of the top 20 pharmaceutical companies' efforts to improve access to healthcare in developing countries.